Not Medicare Enrolled

Dr. Gary Weingarden, MD

Cardiovascular Disease · Richardson, TX
399 W CAMPBELL RD, Richardson, TX 75080
9726993508
Registered in NPPES since 2006
NPI: 1477501724 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weingarden from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weingarden? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weingarden

Dr. Gary Weingarden is a cardiovascular disease specialist in Richardson, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Weingarden received a total of $3,833 from 26 pharmaceutical and/or device companies across 149 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weingarden is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $3,833 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$3,833
Total received (2018-2022)
Avg $767/year across 5 years
Bottom 45% in TX for cardiovascular disease
26
Companies
149
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$409
2021
$581
2020
$545
2019
$823
2018
$1,475

Payments by company (2022)

Novartis Pharmaceuticals Corporation
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
PFIZER INC.
$56
Amgen Inc.
$53
Janssen Pharmaceuticals, Inc
$38
Abbott Laboratories
$34
Esperion Therapeutics, Inc.
$18
Edwards Lifesciences Corporation
$18
AstraZeneca Pharmaceuticals LP
$16
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 53.3% of 2022 payments
All-time payments by company (2018-2022) ›
Abbott Laboratories
$1,133
Amarin Pharma Inc.
$530
Novartis Pharmaceuticals Corporation
$289
Boehringer Ingelheim Pharmaceuticals, Inc.
$286
BOSTON SCIENTIFIC CORPORATION
$247
Janssen Pharmaceuticals, Inc
$159
Astellas Pharma US Inc
$159
PFIZER INC.
$129
E.R. Squibb & Sons, L.L.C.
$125
Amgen Inc.
$119
AstraZeneca Pharmaceuticals LP
$98
Edwards Lifesciences Corporation
$78
Regeneron Healthcare Solutions, Inc.
$58
ARBOR PHARMACEUTICALS, INC.
$56
Kowa Pharmaceuticals America, Inc.
$52
Boston Scientific Corporation
$52
Bardy Diagnostics, Inc.
$38
Esperion Therapeutics, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$36
AtriCure, Inc.
$28
Bard Access Systems, Inc.
$26
iRhythm Technologies, Inc.
$23
Medtronic Vascular, Inc.
$22
Aziyo Biologics, Inc.
$21
Allergan Inc.
$17
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 50.9% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ATRICURE CRYOSURGICAL SYSTEM · Agilis NxT EP Introducer · AtriCure Cryosurgical System · BRILINTA · BYSTOLIC · CONFIRM RX · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · ECM · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Endurant · GENERAL TACHY · Intracardiac Echocardiography (ICE) · JARDIANCE · LEQVIO · LEXISCAN · Livalo · MULTAQ · NEXLETOL · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROGEL · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Repatha · Supera peripheral stent system · VERQUVO · VIGILANT · Vascepa · WATCHMAN · XARELTO · ZIO Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cardiovascular disease specialist in Richardson?
Compare cardiologists in the Richardson area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists in nearby ZIP areas
285
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
3.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2022
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weingarden is a cardiovascular disease specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Weingarden receive payments from pharmaceutical companies?
Yes. Dr. Weingarden received a total of $3,833 from 26 companies across 149 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Weingarden) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →